Earthborn Products Recalls Colloidal Silver Supplement for Lack of FDA Approval
Earthborn Products is recalling 161 gallons of colloidal silver supplements because the FDA determined the product is misbranded and not generally recognized as safe and effective.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The source text does not report specific injuries or illnesses, aligning with a moderate severity rating for a regulatory misbranding issue.
Plain-English summary
Earthborn Products, Inc. is recalling 161 gallons of Colloidal Silver, 100 ppm TDS, Natural Mineral Supplement. The product was sold in various sizes, including 2 fl.oz, 8 fl.oz, 16 fl.oz, 32 fl.oz, 64 fl.oz, and 1 gallon containers, and was distributed nationwide.
The recall was initiated because the FDA issued a final rule establishing that over-the-counter drug products containing colloidal silver ingredients or silver salts for internal or external use are not generally recognized as safe and effective. Consequently, the product is considered misbranded as it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Consumers who have purchased this product should stop using it and contact Earthborn Products for further instructions. The affected lot numbers are 009-22-A011, 011-28-A011, 004-01-A012, 005-24-A012, 007-24-A012, and 008-08-A012.
The recalled product
- Product
- Colloidal Silver, 100 ppm TDS, Natural Mineral Supplement, sold in a) 2 fl.oz (59.15 mL), b) 8 fl.oz (236.6 mL), c) 16 fl.oz (473.2 mL), d) 32 fl.oz (946.4 mL), e) 64 fl.oz (1.89 L), and f) 1 Gal. (3.78 L), Distributed by: Earthborn Products, San Diego, CA 92103.
- Manufacturer
- Earthborn Products, Inc.
- Category
- Drug — OTC Supplement
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: 009-22-A011
- 011-28-A011
- 004-01-A012
- 005-24-A012
- 007-24-A012
- and 008-08-A012.
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- HighDietary Supplement with Unapproved COVID-19 Treatment Claims Recalled
FDA (Food) · 2023-04-26
- CriticalTornado Male Enhancement Supplement Recalled for Undeclared Prescription Drugs
FDA (Drugs) · 2017-07-19
- CriticalSilverback XXX Power male enhancement product recalled for undeclared sildenafil and tadalafil
FDA (Drugs) · 2024-05-01
- CriticalFDA Recalls ZDaily Testosterone Supplement for Undeclared Prescription Drugs
FDA (Drugs) · 2017-07-19
- SevereFDA Recalls Unapproved Caffeine Powder Marketed Without NDA Approval
FDA (Drugs) · 2017-08-23
- SevereDietary supplement recalled for unapproved drug status and pharmaceutical contamination
FDA (Drugs) · 2023-12-13